Al Macki Nabil, Al Rashdi Ismail
Pediatric Neurology Unit, Department of Child Health, Royal Hospital, Muscat, Oman.
Medical Genetics, Royal Hospital, Muscat, Oman.
Oman Med J. 2017 Jan;32(1):66-68. doi: 10.5001/omj.2017.12.
Mutations in the C19orf12 gene are known to cause mitochondrial membrane protein-associated neurodegeneration (MPAN), which is a neurodegeneration with brain iron accumulation (NBIA) type 4 disorder. To the best of our knowledge, this is the first report of a genetically confirmed case of MPAN from Oman. A novel homozygous deletion of exon 2 of the C19orf12 gene was confirmed on the proband, a seven-year-old girl, who presented with gait instability. Brain magnetic resonance imaging showed iron deposition on the basal ganglia. This report highlights the importance of genetic testing of such a clinically and genetically heterogeneous condition among a population with a high consanguinity rate. To overcome the diagnostic difficulty, implementation of a cost-effective approach to perform cascade screening of carriers at risk is needed as well as programs to address risky consanguineous marriages.
已知C19orf12基因突变会导致线粒体膜蛋白相关神经变性(MPAN),这是一种脑铁沉积(NBIA)4型疾病。据我们所知,这是阿曼首例经基因确诊的MPAN病例报告。在先证者(一名患有步态不稳的7岁女孩)身上证实了C19orf12基因第2外显子的新型纯合缺失。脑磁共振成像显示基底神经节有铁沉积。本报告强调了在近亲结婚率高的人群中,对这种临床和基因异质性疾病进行基因检测非常重要。为克服诊断困难,需要实施具有成本效益的方法对有风险的携带者进行级联筛查,以及制定应对有风险的近亲婚姻的方案。